Dr. Jonathan Zenilman, MD

Dr. Zenilman practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Zenilman's NPI, 1730119264, was assigned on July 3, 2006. Dr. Zenilman holds Maryland license D39358.

Dr. Zenilman's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Zenilman's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Zenilman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zenilman practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Zenilman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Zenilman is licensed in Maryland.

CMS data shows 22 Medicare services from Dr. Zenilman across 1 procedure code in 2020, all of them office visits, for 14 Medicare patients. Medicare paid $1,696 for them. Every service was in an office.

CMS counts 14 Medicare patients who saw Dr. Zenilman in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high cholesterol. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zenilman's median patient age at 59, with 83% women.

In 2020, Dr. Zenilman wrote 315 Medicare Part D claims. They cover 15 drugs, with $9,493 in total drug cost. In 2018, CMS named 22 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Zenilman for performance year 2024, reported as part of a group.

Dmand AI links 94 papers to Dr. Zenilman, published from 2002 to 2024. 2015 was the busiest year, with 6. The most frequent topics are Gonorrhea, Sexually Transmitted Diseases and Anti-Bacterial Agents. Dr. Zenilman has published most often in Sex Transm Dis. Dr. Zenilman's most frequent co-authors are Gerald Lazarus, MD, Khalil G. Ghanem, MD and Eric B. Bass, MD.

CMS Open Payments shows 189 general payments to Dr. Zenilman from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 96% of the total. Pfizer Inc. paid the most, $238,168. It also lists 1 research payment totaling $920 in 2018.